BUY GILD — bench-signals (2026-03-20, 7.26 shares @ $137.72)

Desk Move

BUY GILD — bench-signals (2026-03-20, 7.26 shares @ $137.72)

Summary

Gilead HIV/oncology compounder RSI 37.4, golden cross intact. -8.5% 30D. Quality pharma at discount.

Bought 7.26 shares at $137.72.

10 events
DateTypeEvent
Mar 20 ArticleDaily Actions Mar 20 ScanBiotech Scan Mar 20 ScanHealthcare Scan Mar 24 ScanBiotech Scan Mar 24 ScanHealthcare Scan Mar 26 ScanHealthcare Scan Mar 26 ScanBiotech Scan Mar 13 ScanHealthcare Scan Mar 13 ScanBiotech Scan Mar 12 UpdateBiotech

No direct external sources are attached to this read.